Volume 3; Issue S1

Main
HemaSphere
Volume 3; Issue S1

HemaSphere

Volume 3; Issue S1

1

PS1264 FRENCH IBRUTINIB OBSERVATIONAL STUDY (FIRE): REAL-WORLD STUDY OF IBRUTINIB TREATMENT FOR MANTLE CELL LYMPHOMA (MCL) IN FRANCE

Slama, B., Delmer, A., Cartron, G., Anglaret, B., Fitoussi, O., DÃ, K. le, Oberic, L., Peyrade, F., Orfeuvre, H., Senecal, D., Molina, L., Albrecht, C., Thevenon, J., Beauclair, S., Kavanagh, C., Gou

Journal:

Year:

2019

File:

PDF, 297 KB

2019

2

PB2312 PANORAMA OF HEMOGLOBINOPATHIES IN THE ANNABA REGION OF ALGERIA

Djenouni, A., GRIFI, F.

Journal:

Year:

2019

File:

PDF, 201 KB

2019

3

PF201 THE COMBINATION OF IMGN632, A CD123-TARGETING ADC, WITH VENETOCLAX ENHANCES ANTI-LEUKEMIC ACTIVITY IN VITRO AND PROLONGS SURVIVAL IN VIVO IN PRE-CLINICAL MODELS OF HUMAN AML

Adams, S., Zhang, Q., McCarthy, R., Flaherty, L.J., Watkins, K., Sloss, C.M., Romanelli, A., Zweidler-McKay, P., Konopleva, M.

Journal:

Year:

2019

File:

PDF, 351 KB

2019

4

PF393 A RANDOMISED JOINT AUSTRALASIAN (ALLG) AND FRENCH (FILO) STUDY OF LENALIDOMIDE CONSOLIDATION IN PATIENTS WITH RESIDUAL CLL AFTER FRONT-LINE TREATMENT WITH FC/FCR (THE CLL6 TRIAL)

Gottlieb, D., Aurran-Schleinitz, T., Mulligan, S., Letestu, R., Sartor, M., Bene, M., Kuss, B., Delepine, R., Nguyen, U., Butcher, B., Dreyfus, F., Tam, C., Cymbalista, F.

Journal:

Year:

2019

File:

PDF, 317 KB

2019

5

PF416 GROWTH RATE AND ENDOCRINE EFFECTS OF DASATINIB THERAPY OBSERVED IN A RETROSPECTIVE ANALYSIS OF A PHASE 2 CLINICAL TRIAL FOR PEDIATRIC PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)

Patterson, B., Samis, J., Gore, L., Zwaan, C.M., Sacchi, M., Sy, O., Hijiya, N.

Journal:

Year:

2019

File:

PDF, 401 KB

2019

6

PB1700 LOSS OF CHROMOSOME 9 AND/OR 1 HETEROZYGOSITY IN TUMOR CELLS GENOME COME UP WITH ABO AND/OR RH CHANGE IN RELAPSED AML BUT NOT ALL PATIENTS.

Risinskaya, N., Vasilyeva, V., Yushkova, A., Sudarikov, A., Golovkina, L., Stremouchova, A., Pushkina, T., Surin, V., Pshenichnikova, O., Kuzmina, L., Parovichnikova, E., Savchenko, V.

Journal:

Year:

2019

File:

PDF, 342 KB

2019

7

PF432 EPIDEMIOLOGICAL SHIFT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) MUTATIONS IN NORTHERN ITALY DURING THE LAST 15 YEARS

Duca, L., Cappellini, M.D., Nava, I., Tavazzi, D., Marcon, A., Motta, I., Salvatori, M., Mancarella, M., Landi, F., Graziadei, G.

Journal:

Year:

2019

File:

PDF, 326 KB

2019

8

PB2114 NEUTROPHILIC LEUKEMOID REACTION ASSOCIATED WITH SMOLDERING MULTIPLE MYELOMA

MartÃnez-Cordero, H., Valdes-Cespedes, J., Enciso-Olivera, L., Alfaro-Acosta, L., Otero, D., Spirko, P., PatiÃ±o-Escobar, B.

Journal:

Year:

2019

File:

PDF, 300 KB

2019

9

PB1710 ACUTE MYELOID LEUKEMIA WITH A RARE CRYPTIC T(8;16)(P11;P13) TRANSLOCATION AND MYST3/CREBBP FUSION

Brezinova, J., Ransdorfova, S., Valerianova, M., Onderkova, M., Izakova, S., Zemanova, Z., Markova, J., Vitek, A.

Journal:

Year:

2019

File:

PDF, 175 KB

2019

10

S1641 INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING ANTI-CD 19 CHIMERIC ANTIGEN RECEPTORS T-CELLS (CAR T) FOR DIFFUSE LARGE B CELL LYMPHOMA (DLBCL). A MONOCENTRIC PRELIMINARY EXPERIENCE

Di Blasi, R., Aguinaga, L., Paillassa, J., Darmon, M., Bernard, S., Azoulay, E., Lafaurie, M., Thieblemont, C.

Journal:

Year:

2019

File:

PDF, 386 KB

2019

11

PB1887 THE SIGNIFICANCE OF CD43, CD81, CD200, AND ROR1 FOR DIFFERENTIAL DIAGNOSIS OF CLL AS MULTICOLOR FLOW CYTOMETRY

Falay, M., Serdar, M., Dagdas, S., Pepeler, S., Ucar, M.A., Ozet, G.

Journal:

Year:

2019

File:

PDF, 287 KB

2019

12

PF564 OUTCOMES OF PATIENTS WITH T(11;14) MULTIPLE MYELOMA: AN INTERNATIONAL MYELOMA WORKING GROUP MULTICENTER STUDY

Kumar, S., Goldschmidt, H., Mateos, M.-V., Gonzalez, V., Du, J., Kim, K., Merlini, G., Mangiacavalli, S., Min, C.-K., Dimopoulos, M., Kastritis, E., Ludwig, H., Esteves, G., Handa, H., Escalante, F.,

Journal:

Year:

2019

File:

PDF, 762 KB

2019

13

PS1063 RESULTS OF PIVOTAL PHASE 2 CLINICAL TRIAL OF TAGRAXOFUSP (SL-401) IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM (BPDCN)

Pemmaraju, N., Lane, A., Sweet, K., Stein, A., Vasu, S., Rizzieri, D., Wang, E., Duvic, M., Spence, S., Shemesh, S., Brooks, C., Bergstein, I., Chen, J., McDonald, P., Sloan, J.M., Rosenblat, T., Akil

Journal:

Year:

2019

File:

PDF, 161 KB

2019

14

PS1003 HARMONY ALLIANCE: EUROPEAN PUBLIC-PRIVATE DATA COLLECTION LEADS THE WAY - FIRST RESULTS OF THE âPROOF-OF-PRINCIPLEâ STUDY IN ACUTE MYELOID LEUKEMIA

Bullinger, L., Valk, P., Versluis, J., Metzeler, K., Ayala, R., Lopez, J. Martinez, Dombret, H., Montesinos, P., Sierra, J., Preudhomme, C., Damm, F., Mills, K., Mayer, J., Thiede, C., Voso, M.T., Ama

Journal:

Year:

2019

File:

PDF, 166 KB

2019

15

PS1002 RHOE, CXCL12 AND CXCR3 MAY IDENTIFY COMPLETE RESPONSES IN ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH TIPIFARNIB

Gualberto, A., Scholz, C., Mishra, V., Janes, M.R., Kessler, L.

Journal:

Year:

2019

File:

PDF, 306 KB

2019

16

PS1006 INHIBITORS OF HOXA9 LEUKEMOGENIC TRANSCRIPTION FACTOR ARE EFFICIENT ON HUMAN AML CELL MODELS BUT NOT ON NORMAL HUMAN BONE MARROW CD34+ HEMATOPOIETIC CELLS

Lambert, M., Depauw, S., Jambon, S., Bellart, M., Lutchmee, L., Louis-ThÃ©rÃ¨se, L., Nhili, R., David-Cordonnier, M.-H.

Journal:

Year:

2019

File:

PDF, 179 KB

2019

17

PS1323 HIGH SERUM LEVELS OF IL-2R, IL-6 AND TNF ARE ASSOCIATED WITH HIGHER TUMOR BURDEN AND POORER OUTCOME IN PATIENTS WITH NEWLY DIAGNOSED FOLLICULAR LYMPHOMA

Mozas, P., Magnano, L., Rivas-Delgado, A., Rivero, A., Dlouhy, I., Baumann, T., Veloza, L., GonzÃ¡lez-FarrÃ©, B., GinÃ©, E., Delgado, J., Villamor, N., Campo, E., Filella, X., LÃ³pez-Guillermo, A.

Journal:

Year:

2019

File:

PDF, 622 KB

2019

18

PS1577 PLATELET COUNT AND MEAN PLATELET VOLUME IN ACUTE STROKE: A SYSTEMATIC REVIEW AND META-ANALYSIS

Shemirani, H.A., Sadeghi, F., KovÃ¡cs, S., ZsÃ³ri, K.S., Bereczky, Z., csiki, Z.

Journal:

Year:

2019

File:

PDF, 202 KB

2019

19

PF229 CLUSTER ANALYSIS IDENTIFIES A SPECIFIC IMMUNOPHENOTYPIC PROFILE ASSOCIATED WITH HIGH RISK OF PRIMARY INDUCTION FAILURE AND SHORTER OVERALL AND DISEASE-FREE SURVIVAL IN NPM1-MUTATED AML

Piccini, M., Bencini, S., Maria Ida, B., Francesco, M., Gianfaldoni, G., grieco, P., pilerci, S., scappini, B., peruzzi, B., Palterer, B., caporale, R., annunziato, F., pancani, F., signori, L., bosi,

Journal:

Year:

2019

File:

PDF, 632 KB

2019

20

PF254 RESULTS FROM THE FIRST-IN-HUMAN STUDY OF MIVEBRESIB (ABBV-075), A PAN-INHIBITOR OF BROMODOMAIN AND EXTRA TERMINAL PROTEINS, IN PATIENTS WITH RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA

Borthakur, G., Odenike, O., Wolff, J.E., Aldoss, I., Rizzieri, D., Prebet, T., Hu, B., Dinh, M.H., Chen, X., Modi, D.A., Freise, K.J., Jonas, B.A.

Journal:

Year:

2019

File:

PDF, 422 KB

2019

21

PF260 PROGNOSTIC AND PREDICTIVE IMPACT OF NPM1/FLT3-ITD GENOTYPES AS DEFINED BY 2017 EUROPEAN LEUKEMIANET RISK CATEGORIZATION FROM AML PATIENTS TREATED WITHIN THE INTERNATIONAL RATIFY STUDY

DÃ¶hner, K., Thiede, C., Jahn, N., Ekaterina, P., Gambietz, A., Prior, T.W., Marcucci, G., Jones, D., Krauter, J., Michael, H., Lo-Coco, F., Ottone, T., Nomdedeu, J., Mandrekar, S.J., Huebner, L., Lau

Journal:

Year:

2019

File:

PDF, 471 KB

2019

22

PF276 QUALITY OF LIFE EVALUATION IN LONG TERM SURVIVORS WITH ACUTE MYELOID LEUKEMIA: A SINGLE CENTER EXPERIENCE

Tarantini, F., Carluccio, P., Carluccio, V., Delia, M., Attolico, I., Ricco, A., Mallano, S., Frappampina, R., Mestice, A., Impera, L., Albano, F., Specchia, G.

Journal:

Year:

2019

File:

PDF, 419 KB

2019

23

PF294 IMPROVED OUTCOMES IN PATIENTS (PTS) WITH BCL2-POSITIVE DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) TREATED WITH VENETOCLAX (VEN) PLUS R-CHOP: RESULTS FROM THE PHASE 2 CAVALLI STUDY

Morschhauser, F., Feugier, P., Flinn, I.W., Gasiorowski, R., Greil, R., IllÃ©s, Ã., Johnson, N.A., Larouche, J.-F., Lugtenburg, P.J., Patti, C., Salles, G., TrnÄnÃ½, M., de Vos, S., Mir, F., Kornack

Journal:

Year:

2019

File:

PDF, 484 KB

2019

24

PF301 REDUCED-INTENSITY IMMUNOCHEMOTHERAPY WITHOUT VINCRISTINE IN ELDERLY PATIENTS OLDER THAN 80 YEARS OLD WITH DIFFUSE LARGE B-CELL LYMPHOMA: A MULTICENTRE, OPEN-LABEL, SINGLE-ARM, PHASE II TRIAL

Yoshida, I., Suehiro, Y., Hirabayashi, Y., Hidaka, M., Komeno, T., Hishita, T., Ueno, H., Sunami, K., Iwasaki, H., Ogata, Y., Yoshida, S., Kurosawa, M., Saito, A., Nagai, H., Miyata, Y.

Journal:

Year:

2019

File:

PDF, 311 KB

2019

25

PF329 INTRACRANIAL HEMORRHAGE IN IMMUNE THROMBOCYTOPENIA: A SINGLE-CENTRED STUDY OF 36 PATIENTS

zhao, P., zeng, Q., meng, X., liu, X., wang, Y., su, Y., zhang, G., wang, C., fu, H., jiang, Q., jiang, H., lu, J., huang, X., xu, L., zhang, X.

Journal:

Year:

2019

File:

PDF, 181 KB

2019

26

PF335 MUTATION SPECTRUM OF F8 GENE IN HEMOPHILIA A PATIENTS FROM RUSSIA

Pshenichnikova, O., Salomashkina, V., Surin, V., Likhacheva, E., Zozulya, N., Perina, F.

Journal:

Year:

2019

File:

PDF, 430 KB

2019

27

PF349 57 PATIENTS WITH HAX1 ASSOCIATED CONGENITAL NEUTROPENIA: AN ANALYSIS OF THE EUROPEAN SEVERE CHRONIC NEUTROPENIA INTERNATIONAL REGISTRY (SCNIR)

Zeidler, C., Mellor-Heineke, S., Froemling, F., Gerschmann, N., Skokowa, J., Welte, K.

Journal:

Year:

2019

File:

PDF, 588 KB

2019

28

PF380 SINGLE CELL ABNORMALITIES ON CLASSIC G-BANDING ANALYSIS OF CHRONIC LYMPHOCYTIC LEUKEMIA: CLINICOBIOLOGICAL FEATURES AND PROGNOSTIC VALUE

Athanasiadou, A., Gkaitatzi, M., Papaioannou, G., Iskas, M., Asteriou, O., Lazarou, Z., Papalexandri, A., Banti, A., Stavroyianni, N., Anagnostopoulos, A.

Journal:

Year:

2019

File:

PDF, 181 KB

2019

29

PF398 KNOCKDOWN OF LASP1 IN CXCR4 EXPRESSING CML CELLS PROMOTES CELL PERSISTENCE, PROLIFERATION AND TKI RESISTANCE

Herrmann, A.B., MÃ¼ller, M.-L., Orth, M.F., MÃ¼ller, J.P., Zernecke, A., Hochhaus, A., Ernst, T., Butt, E., Frietsch, J.J.

Journal:

Year:

2019

File:

PDF, 166 KB

2019

30

PF415 EFFICACY AND SAFETY FOLLOWING DOSE REDUCTION OF BOSUTINIB IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA: ANALYSIS OF THE PHASE 4 BYOND TRIAL

BrÃ¼mmendorf, T.H., Giles, F., Gambacorti-Passerini, C., Roboz, G.J., Le Coutre, P., Hjorth-Hansen, H., Stenke, L., Cervantes, F., Rousselot, P., Viqueira, A., Bardy-Bouxin, N., Leip, E., Leone, J.M.,

Journal:

Year:

2019

File:

PDF, 700 KB

2019

31

PF529 PROGNOSTIC CORRELATION OF CELL-OF-ORIGIN AND MYC, BCL-2 AND BCL-6 STATUS IN HIV-ASSOCIATED DIFFUSE LARGE B-CELL LYMPHOMAS

Crucitti, L., Rusconi, C., Re, A., Bandiera, L., Spina, M., Gini, G., Paulli, M., Lucioni, M., Facchetti, F., Goteri, G., Canzonieri, V., Lorenzi, L., Balzarini, P., Fisogni, S., Riboni, R., Malfitano

Journal:

Year:

2019

File:

PDF, 280 KB

2019

32

PF540 TERT PROMOTER METHYLATION AS A POTENTIAL PROGNOSTIC BIOMARKER FOR PROGRESSION OF UNEXPLAINED CYTOPENIA TO MDS AND AML

Kaastrup, K., Gillberg, L., Aslan, D., Kristensen, L.S., Ãrskov, A.D., Hansen, J.W., GrÃ¸nbÃ¦k, K.

Journal:

Year:

2019

File:

PDF, 477 KB

2019

33

PF595 POMALIDOMIDE + BORTEZOMIB + LOW-DOSE DEXAMETHASONE AFTER ONE PRIOR LINE OF THERAPY IN PATIENTS WITH LENALIDOMIDE-PRETREATED MULTIPLE MYELOMA: SUBGROUP ANALYSIS OF THE PHASE 3 OPTIMISMM TRIAL

Dimopoulos, M., Weisel, K., Moreau, P., Jr, L.D. Anderson, White, D., Miguel, J. San, Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., DÃ¼rig, J., Pavic, M., Salomo, M., Yu, X., Nguyen, T. Vi, Be

Journal:

Year:

2019

File:

PDF, 849 KB

2019

34

PF620 COMPARISON OF RISS AND IMWG RISK STRATIFICATION GUIDELINES WITH GENE EXPRESSION PROFILE SKY92 IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; RESULTS FROM THE PROMMIS TRIAL

Hari, P., Lentzsch, S., Siegel, D., Usmani, S.Z., Dhakal, B., Rossi, A., Rosenbaum, C., Leng, S., Bhutani, D., Bhutani, M., Biran, N., Vesole, D., Stork-Sloots, L., de Snoo, F., Dumee, B., van Vliet,

Journal:

Year:

2019

File:

PDF, 297 KB

2019

35

PF638 VENOUS AND ARTERIAL THROMBOTIC EVENTS IN MYELOMA PATIENTS TREATED WITH IXAZOMIB, LENALIDOMIDE AND DEXAMETHASONE (IRD) OR LENALIDOMIDE AND DEXAMETHASONE (RD)

Sayar, Z., Yi, K., Cheesman, S., Chavda, S., Lee, L., Kyriakou, C., Papanikolaou, X., Sachchithanantham, S., Mahmood, S., Mehta, A., Popat, R., Wechalekar, A., Yong, K., Rabin, N.

Journal:

Year:

2019

File:

PDF, 160 KB

2019

36

PF681 IMPACT OF MYELOPROLIFERATIVE NEOPLASMS (MPNS) AND PERCEPTIONS OF TREATMENT GOALS AMONGST PHYSICIANS AND PATIENTS IN 6 COUNTRIES: AN EXPANSION OF THE MPN LANDMARK SURVEY

Xiao, Z., Chang, C.-S., Morozova, E., Bang, S.-M., Alzahrani, M., Mycock, K., Rajkovic, I., Siddiqui, A., Saydam, G.

Journal:

Year:

2019

File:

PDF, 707 KB

2019

37

PF691 SPLENECTOMY IN IMMUNE THROMBOCYTOPENIA: DO CHANGING TREATMENT PATTERNS FOR ITP AFFECT OUTCOMES? DATA FROM THE UK ITP REGISTRY

Todd, S., Infirri, S. Sardo, Miah, H., Miah, A., Zaidi, A., Taylor, L., Chen, F., Allsup, D., Biss, T., Bagot, C., Scully, M., Garcia, S., Cooper, N., Hill, Q., Mahalakshmi, M., Hall, C., Garg, M., Ch

Journal:

Year:

2019

File:

PDF, 372 KB

2019

38

PF706 OCCULT BLEEDING IN CHILDREN WITH IMMUNE THROMBOCYTOPENIA: RELATION TO LABORATORY PARAMETERS &ITP HEALTH QUALITY OF LIFE

Tantawy, A., Elsherif, N., Aboulfotouh, K., Kenny, M.

Journal:

Year:

2019

File:

PDF, 505 KB

2019

39

PF788 DATA FROM THE FRENCH REGISTRY FOR BETA-THALASSEMIA PATIENTS

Agouti, I., Thuret, I., Bernit, E., Galacteros, F., Steschenko, D., Brousse, V., Rose, C., HOT, A., Ribeil, J.-A., Pegourie, B., Lambilliotte, A., Lionnet, F., Auguste, Y., Loundou, A., Badens, C.

Journal:

Year:

2019

File:

PDF, 264 KB

2019

40

PF796 THE EFFECT OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODY UPON THROMBIN GENERATION IN NORMAL, LEIDEN HETEROZYGOUS AND FACTOR DEFICIENT PLASMAS

SzabÃ³, G., Tarr, T., SoltÃ©sz, P., Kappelmayer, J.

Journal:

Year:

2019

File:

PDF, 583 KB

2019

41

S834 PEGCRISANTASPASE AND VENETOCLAX COMBINATION IS HIGHLY EFFECTIVE AGAINST ACUTE MYELOID LEUKEMIA (AML), MECHANISTICALLY DRIVEN SYNERGISM BETWEEN GLUTAMINE DEPLETION AND BCL-2 INHIBITION

Emadi, A., Gartenhaus, R., Bhandary, B., Kaizer, H., Chang, E., Choi, E.Y., Carter-Cooper, B., Shetty, A., Mahurkar, A., Kapadia, B., Lapidus, R.

Journal:

Year:

2019

File:

PDF, 1.04 MB

2019

42

S904 THE FUNCTIONAL RESPONSE OF IRON-RECYCLING AND INFECTION CONTROL-SPECIALIZED MACROPHAGES IS IMPAIRED BY TRANSFUSIONS AND AMELIORATED BY IRON CHELATION

Passos, S., Sparla, R., Rauner, M., Weidner, H., Yazdanbakhsh, K., Platzbecker, U., Muckenthaler, M.U., Vinchi, F.

Journal:

Year:

2019

File:

PDF, 195 KB

2019

43

PS975 HIGH-RESOLUTION CLONAL ANALYSIS OF TUMORS WITH SIMULTANEOUS SINGLE-CELL DNA SEQUENCING AND CELL SURFACE PHENOTYPING

Eastburn, D., Delley, C., Demaree, B., Dhingra, D., Mendez, P., Ruff, D., Abate, A.

Journal:

Year:

2019

File:

PDF, 319 KB

2019

44

PS1000 POST-TRANSLATIONAL MODIFICATIONS OF PROTEIN PHOSPHATASE 2A (PP2A) IN MIXED LINEAGE LEUKEMIA (MLL)

Arroyo-Berdugo, Y., Di Mambro, A., Calle-Patino, Y., Wrench, B., Gribben, J., Esposito, M.T.

Journal:

Year:

2019

File:

PDF, 292 KB

2019

45

PS1018 TUMOR IMMUNE ESCAPE MEDIATED BY TH17CCR4-CCR6+ CELLS AND IL-6/IL-10/IL-17A IN ACUTE MYELOID LEUKEMIA

Zabalza, A., Soria, E., Vallejo, M., Mansilla, C., Alvarellos, M., GarcÃa-Ramirez, P., Ardaiz, M.Ã., Mateos, M.C., Ramirez, N.

Journal:

Year:

2019

File:

PDF, 214 KB

2019

46

PS1092 TANDEM AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR TREATMENT OF ADULT T-CELL LYMPHOBLASTIC LYMPHOMA: A MULTIPLE CENTER PROSPECTIVE STUDY IN SOUTHWESTERN CHINA

Liu, Y., Li, J., Rao, J., Wen, Q., Wang, S., Lou, S., Yang, T., Li, B., Gao, L., Zhang, C., Kong, P., Gao, L., Wang, M., Zhu, L., Xiang, X., Zhou, S., Liu, X., Peng, X., Chen, X., Zhong, J., Zhang, X.

Journal:

Year:

2019

File:

PDF, 297 KB

2019

47

PS1094 MANAGING CYTOKINE RELEASE SYNDROME (CRS) AND NEUROTOXICITY WITH STEP-FRACTIONATED DOSING OF MOSUNETUZUMAB IN RELAPSED/REFRACTORY (R/R) B-CELL NON-HODGKIN LYMPHOMA (NHL)

Yoon, S.-S., Matasar, M., Sehn, L.H., Assouline, S., Bartlett, N.L., Bosch, F., Diefenbach, C.M., Flinn, I., Hong, J.Y., Kim, W.S., Nastoupil, L., Schuster, S.J., Shadman, M., Bender, B., Chu, W., Her

Journal:

Year:

2019

File:

PDF, 468 KB

2019

48

PS1109 DENTAL HEALTH STATUS IN PATIENTS WITH HEMOPHILIA. SINGLE CENTER EXPERIENCE IN ROMANIA

Ursu, C.E., Serban, M., Clevet, O., Traila, A., Boeriu, E., Jinca, C., Boia, E., Arghirescu, S.

Journal:

Year:

2019

File:

PDF, 209 KB

2019

49

PS1133 GENOMIC ARRAYS IDENTIFY HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA WITH GENOMIC COMPLEXITY: A MULTI-CENTER STUDY

Leeksma, A., Baliakas, P., Moysiadis, T., Mellink, C., Puiggros, A., Plevova, K., van der Kevie, A.-M., Tran, A.N., Gunnarsson, R., Parker, H., van den Berg, E., Ghia, P., Espinet, B., Pospisilova, S.

Journal:

Year:

2019

File:

PDF, 253 KB

2019

50

PS1138 TUMOR MUTATIONAL BURDEN ASSESSED BY TARGETED HIGH THROUGHPUT SEQUENCING PREDICTS TREATMENT FREE SURVIVAL IN CLL: RESULTS FROM A BICENTER STUDY

Chauzeix, J., Pastoret, C., Donaty, L., Gachard, N., Fest, T., Feuillard, J., Rizzo, D.

Journal:

Year:

2019

File:

PDF, 287 KB

2019

51

PS1156 HAMPERED EFFECTIVENESS OF SECOND-LINE TREATMENT WITH RITUXIMAB-BASED CHEMOTHERAPY WITHOUT SIGNS OF RITUXIMAB RESISTANCE: A POPULATION-BASED STUDY AMONG PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Van Der Straten, L., Kater, A.P., Doorduijn, J.K., Van den Broek, E.C., Posthuma, E.F., Dinmohamed, A.G., Levin, M.-D.

Journal:

Year:

2019

File:

PDF, 409 KB

2019

52

PS1157 EFFECT OF DOSE MODIFICATIONS ON RESPONSE TO DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL/SLL IN THE DUO TRIAL

Ghia, P., Flinn, I., Lamanna, N., Montillo, M., IllÃ©s, Ã., Etienne, G., Delgado, J., Kuss, B., Tam, C., Offner, F., Bosch, F., Davids, M., JÃ¤ger, U., Cymbalista, F., Weaver, D., Lustgarten, S., You

Journal:

Year:

2019

File:

PDF, 488 KB

2019

53

PS1166 LONGITUDINAL TREATMENT PATTERNS AND OUTCOMES OF CHRONIC LYMPHOCYTIC LEUKEMIA IN ISRAEL (2009â2018)

Weil, C., Chodick, G., Shalev, V., Kan, I., Afik, R., Cohen, R., Sail, K., Herishanu, Y.

Journal:

Year:

2019

File:

PDF, 652 KB

2019

54

PS1167 INDIVIDUAL RESPONSE OF CML PATIENTS TO TKI DOSE REDUCTION CAN RELIABLY IDENTIFY PATIENTS WITH HIGH RISK OF MOLECULAR RELAPSE AFTER TREATMENT CESSATION

Gottschalk, A., Glauche, I., Clark, R., RÃ¶der, I.

Journal:

Year:

2019

File:

PDF, 396 KB

2019

55

PS1170 INFLUX/EFFLUX TRANSPORTERS IN CHRONIC MYELOID LEUKEMIA: THE INFLUENCE OF GENETIC VARIANTS ON SUSCEPTIBILITY AND DRUG RESPONSE

Alves, R.S., GonÃ§alves, A., Jorge, J., Marques, G., Ribeiro, A. Barbosa, Tenreiro, R., Coucelo, M., Diamond, J., Pereira, A., Freitas-Tavares, P., Almeida, A.M., Sarmento-Ribeiro, A.B.

Journal:

Year:

2019

File:

PDF, 382 KB

2019

56

PS1254 CHARACTERISTICS AND OUTCOME OF PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA AFTER RETREATMENT WITH SECOND-LINE RITUXIMAB-CONTAINING CHEMOTHERAPY

Liu, J., Biccler, J.L., Stewart, D., Fontaine, A., Fleury, I., Mollica, L., Prica, A., Buckstein, R., Kuruvilla, J., Villa, D.

Journal:

Year:

2019

File:

PDF, 165 KB

2019

57

PS1312 QPCR, MFC AND DDPCR: COMPARISON ON MRD SAMPLES FROM THREE PROSPECTIVE TRIALS OF THE EUROPEAN MCL NETWORK

Drandi, D., Alcantara, M., Barbero, D., Benmaad, I., Lhermitte, L., Ferrante, M., Zaccaria, G.M., Mantoan, B., Genuardi, E., Ruggeri, M., OmedÃ¨, P., Villarese, P., Cheminant, M., Cortelazzo, S., Pott

Journal:

Year:

2019

File:

PDF, 390 KB

2019

58

PS1327 PRO-NECROPTOTIC RIPK3 AS A STAGE-DEPENDENT MARKER IN THE BONE MARROW OF PATIENTS WITH MDS AND CMML

Dill, V., Jilg, S., Wagner, C., Hauch, R., Buschhorn, L., Odinius, T., Kauschinger, J., Wahida, A., HÃ¶ckendorf, U., Slotta-Huspenina, J., Prodinger, P., Schmidt, B., MÃ¼ller-Thomas, C., Haferlach, T.

Journal:

Year:

2019

File:

PDF, 292 KB

2019

59

PS1375 UPDATED SAFETY AND EFFICACY FROM A PHASE 2 STUDY OF VENETOCLAX PLUS CARFILZOMIB AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Costa, L., Stadtmauer, E., Davies, F., Monohan, G., Kovacsovics, T., Burwick, N., Jakubowiak, A., Kaufman, J., Hong, W.-J., Freise, K., Ross, J., Pesko, J., Munasinghe, W., Gudipati, S., Mudd, S., Bue

Journal:

Year:

2019

File:

PDF, 471 KB

2019

60

PS1418 POMALIDOMIDE-BASED TREATMENT IN RELAPSED REFRACTORY MULTIPLE MYELOMA: ANALYSIS OF BASELINE CHARACTERISTICS AND SAFETY PROFILE OF PATIENTS WHO DIED IN THE EUROPEAN POST APPROVAL SAFETY STUDY

Gamberi, B., Abildgaard, N., Payer, A. Ramirez, Kyriakou, C., Hieber, M. Schmidt, Di Raimondo, F., Kueenburg, E., Di Micco, A., Rosettani, B., Atiba-Davies, M., Bacon, P., Plesner, T.

Journal:

Year:

2019

File:

PDF, 285 KB

2019

61

PS1419 COMPARATIVE EFFECTIVENESS OF TRIPLETS CONTAINING BORTEZOMIB (B), CARFILZOMIB (C), DARATUMUMAB (D), OR IXAZOMIB (I) IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) IN ROUTINE CARE IN THE US

Davies, F., Rifkin, R., Costello, C., Usmani, S., Abonour, R., Palumbo, A., Romanus, D., Hajek, R., Terpos, E., Stull, D.M., Huang, H., Leleu, X., Berdeja, J., Lee, H., Weisel, K., Thompson, M., Bocca

Journal:

Year:

2019

File:

PDF, 1.10 MB

2019

62

PS1422 VENETOCLAX FOR THE TREATMENT OF MULTIPLE MYELOMA: OUTCOMES OUTSIDE OF CLINICAL TRIALS

Sidiqi, M.H., Saleh, A.S. Al, Kumar, S., Morie, G., Dispenzieri, A., Buadi, F., Lacy, M., Leung, N., Muchtar, E., Kyle, R., Go, R., Hobbs, M., Gonsalves, W., Kourelis, T., Warsame, R., Dingli, D., Lus

Journal:

Year:

2019

File:

PDF, 501 KB

2019

63

PS1442 PROTEASOME INHIBITOR CARFILZOMIB HAS SYNTHETIC LETHALITY WITH RUXOLITINIB IN MYELOPROLIFERATIVE NEOPLASMS

Claudiani, S., Mason, C.C., Fiol, C. Ripoll, Mokretar, K., Milojkovic, D., Deininger, M., Apperley, J., Khorashad, J.

Journal:

Year:

2019

File:

PDF, 174 KB

2019

64

PS1523 THE OXYGENSCAN: A COMPREHENSIBLE FUNCTIONAL RED BLOOD CELL TEST TO MONITOR TREATMENT EFFICACY IN PATIENTS WITH SICKLE CELL DISEASE

Rab, M., Houwing, M., Nur, E., de Pagter, A., Bos, J., van Oirschot, B., Bartels, M., Cnossen, M., van Wijk, R., van Beers, E.

Journal:

Year:

2019

File:

PDF, 597 KB

2019

65

PS1530 POST-TRANSPLANT CYCLOPHOSPHAMIDE IN HLA MATCHED AND HAPLOIDENTICAL TRANSPLANT RECIPIENTS RECEIVING MYELOABLATIVE TIMED SEQUENTIAL BUSULFAN CONDITIONING REGIMEN: RESULTS OF A PHASE II STUDY

Mehta, R., Bassett, R., Olson, A., Chen, J., Ganesh, C., Alousi, A., Anderlini, P., Al-Atrash, G., Bashir, Q., Ciurea, S., Hosing, C., Im, J., Jones, R., Kebriaei, P., Khouri, I., Marin, D., Molldrem,

Journal:

Year:

2019

File:

PDF, 317 KB

2019

66

S1601 NIVOLUMAB COMBINED WITH BRENTUXIMAB VEDOTIN FOR RELAPSED/REFRACTORY PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA: EFFICACY AND SAFETY RESULTS FROM THE PHASE 2 CHECKMATE 436 STUDY

Zinzani, P.L., Santoro, A., Gritti, G., Brice, P., Barr, P.M., Kuruvilla, J., Cunningham, D., Kline, J., Johnson, N.A., Mehta-Shah, N.A., Manley, T., Francis, S., Sharma, M., Moskowitz, A.J.

Journal:

Year:

2019

File:

PDF, 281 KB

2019

67

S1605 HORIZON (OP-106): UPDATED EFFICACY AND SAFETY OF MELFLUFEN IN RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) REFRACTORY TO DARATUMUMAB (DARA) AND/OR POMALIDOMIDE (POM)

Richardson, P.G., Oriol, A., Larocca, A., Otero, P. R., Norkin, M., BladÃ©, J., Cavo, M., Hassoun, H., Leleu, X., Alegre, A., Maisel, C., Paner, A., Mazumder, A., Zonder, J. A., Puig, N., Harran, J.,

Journal:

Year:

2019

File:

PDF, 440 KB

2019

68

S1616 MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA (AML) WITH T(8;21)(Q22;Q22.1); RUNX1-RUNX1T1: RESULTS OF THE AML STUDY GROUP (AMLSG)

RÃ¼cker, F.G., Agrawal, M., Corbacioglu, A., Weber, D., Kapp-Schwoerer, S., Gaidzik, V.I., Jahn, N., Schroeder, T., Wattad, M., LÃ¼bbert, M., Koller, E., Kindler, T., GÃ¶tze, K., Ringhoffer, M., Weste

Journal:

Year:

2019

File:

PDF, 490 KB

2019

69

S1620 NELARABINE AS SALVAGE THERAPY AND BRIDGE TO ALLOGENEIC STEM CELLS TRANSPLANTATION IN 118 ADULT PATIENTS WITH RELAPSED/REFRACTORY T-ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA. A CAMPUS-ALL, PHASE 4, STUDY.

Candoni, A., Lazzarotto, D., Curti, A., Ferrara, F., Lussana, F., Papayannidis, C., Del Principe, M.I., Bonifacio, M., Mosna, F., Delia, M., Minetto, P., Gottardi, M., Fracchiolla, N., Mancini, V., Fo

Journal:

Year:

2019

File:

PDF, 279 KB

2019

70

PB1693 MONOSOMAL KARYOTYPE IN ADULT ACUTE MYELOID LEUKEMIA

Zotova, O., Lukianova, A., Valchuk, M., Vanko, I., Karol, Y., Shalay, O., Loginsky, V.

Journal:

Year:

2019

File:

PDF, 283 KB

2019

71

PB1705 CBC PARAMETERS BASED DERIVED PREDICTIVE FACTOR FOR ACUTE PROMYELOCYTE LEUKEMIA

Haider, R.Z.H., Buoro, S., Simon-Lopez, R., De Paula, E., Shamsi, T.S.

Journal:

Year:

2019

File:

PDF, 165 KB

2019

72

PB1750 ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IMPROVES SURVIVAL IN AML PATIENTS WITH HIGH FLT3-ITD ALLELIC RATIO

Papalexandri, A., Kika, F., Varelas, C., Paleta, A., Marvaki, A., Mouratidou, E., Konstantinidou, G., Syrigou, A., Papathanasiou, M., Tsompanakou, A., Athanasiadou, A., Boussiou, Z., Touloumenidou, T.

Journal:

Year:

2019

File:

PDF, 164 KB

2019

73

PB1751 HOW WE TREAT PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA AND ACUTE MYELOID LEUKEMIA DEVELOPED FROM MYELODYSPLASTIC SYNDROME

Mikhaleva, M., Kuvshinov, A., Kuzyaeva, A., Voloshin, S., Martynkevich, I., Kleina, E., Rysev, G.

Journal:

Year:

2019

File:

PDF, 152 KB

2019

74

PB1752 REAL WORLD COMPARISON OF THE TWO HYPOMETHYLATING AGENTS IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS- SINGLE INSTITUTION EXPERIENCE FROM INDIA

C. R,, BABU, G., L. K C,, ABRAHAM JACOB, L., L. D,, S.B. M C,, L. K N,, R. A H,, R. L K,, Koppaka, D., Asati, V., Patidar, R.

Journal:

Year:

2019

File:

PDF, 153 KB

2019

75

PB1798 EFFICACY AND TOLERABILITY OF R-MINICHOP IMMUNOCHEMOTHERAPY IN ELDERLY PATIENTS WITH HIGH GRADE NON-HODGKIN LYMPHOMA: REAL WORLD EXPERIENCE AT A RURAL UK HOSPITAL.

OâFarrell, F.M., Rozi, N.R., Khan, D.Z., Cooke, L.J., Idris, S.F.

Journal:

Year:

2019

File:

PDF, 552 KB

2019

76

PB1809 REAL-WORLD HEALTHCARE RESOURCE UTILIZATION (HRU) AND COSTS OF PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMBCL) PATIENTS INITIATED ON ANTI-CANCER THERAPIES IN THE UNITED STATES (US)

Yang, X., LalibertÃ©, F., Germain, G., Raut, M., Duh, M.S., Sen, S.S., Lejeune, D., Desai, K., Armand, P.

Journal:

Year:

2019

File:

PDF, 297 KB

2019

77

PB1812 PHARMACO-ECONOMY ANALYSIS OF THE THREATMENT WITH R-DA-EPOCH, R-CHOP, AND CHOP-LIKE REGIMENS IN HIGH-RISK PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (UKRAINIAN MULTICENTER STUDY)

Filonenko, K., Kriachok, I., Martynchyk, A., Titorenko, I., Stepanischyna, Y., Aleksyk, O., Ulianchenko, K., Pastushenko, I., Kushchevyy, E., Novosad, O., Karnabeda, O., Dyagil, I., Martina, Z., Kozlo

Journal:

Year:

2019

File:

PDF, 296 KB

2019

78

PB1879 MULTIPARAMETRIC FLOW-CYTOMETRY ANALYSIS OF SURFACE MARKERS EXPRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: PATHOGENIC AND PROGNOSTIC IMPLICATIONS.

Guastafierro, S., Spada, A., Ferrara, M.G., Scalia, G., Raia, M., Falcone, U., Parascandola, R.R., Miranda, G., Sica, A., Chiurazzi, F., Lucivero, G.

Journal:

Year:

2019

File:

PDF, 443 KB

2019

79

PB1889 PROGNOSTIC VALUE OF MICRORNA-223 IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

Berezina, O.V., Basharova, R.R., Perepechaeva, M.L., Agakishiev, M.M., Kovinev, I.B., Nechunaeva, I.N., Grishanova, A.Y., Pospelova, T.I.

Journal:

Year:

2019

File:

PDF, 189 KB

2019

80

PB1931 CARDIO-ONCOLOGY UNIT IMPROVE THE MANAGEMENT OF TREATMENT WITH TKIS OF CHRONIC MYELOID LEUKEMIA PATIENTS: A SINGLE CENTER EXPERIENCE.

Spinosa, G., CAPALBO, S.F., CASAVECCHIA, G., ZICCHINO, S., DEL MASTRO, M., BRUNETTI, N.D.

Journal:

Year:

2019

File:

PDF, 268 KB

2019

81

PB1953 QUALITY OF LIFE AND SYMPTOM BURDEN WITH FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA

Toptas, T., Bostan, H., Kut, K., Pepedil Tanrikulu, F., Yilmaz, F., Atagunduz, I., Tuglular, T.

Journal:

Year:

2019

File:

PDF, 588 KB

2019

82

PB1974 PYRUVATE KINASE DEFICIENCY IN FOUR CHILDREN WITH TWO UNPUBLISHED MUTATIONS

Unal, E., Gok, V., Roy, N.B.A., Hipkiss, R., Howard, K., Ozcan, A., Yilmaz, E., Karakukcu, M., Henderson, S., PatÄ±roglu, T.

Journal:

Year:

2019

File:

PDF, 441 KB

2019

83

PB2020 EARLY RELAPSED FOLLICULAR LYMPHOMA- IS IT NEW ENTITY WITH DIFFERENT TREATMENT APPROACH?

PuriÄ, M., Milanovic, N., Ristic, D., Djordjevic, F.

Journal:

Year:

2019

File:

PDF, 167 KB

2019

84

PB2068 THE CASTLEMAN DISEASE: HISTOLOGICAL VARIANTS, POEMS-SYNDROME AND PRODUCTIVE PLASMA CELL VASCULITIS

Mihailov, A., Bessmeltsev, S., Rugal, V., Semenova, N., Khmelnitskaya, N.

Journal:

Year:

2019

File:

PDF, 190 KB

2019

85

PB2131 CTDA VERSUS MPT FOR MULTIPLE MYELOMA: REAL WORLD DATA FROM THE WEST OF SCOTLAND CANCER NETWORK

Steel, M., Walbaum, C., Donaldson, A., Soutar, R.

Journal:

Year:

2019

File:

PDF, 280 KB

2019

86

PB2201 PROGRESS AND SURVIVAL IN TRIPLE NEGATIVE PRIMARY MYELOFIBROSIS PATIENTS

Potre, C., Borsi, E., Samfireag, M., Pescaru, M., Potre, O.

Journal:

Year:

2019

File:

PDF, 295 KB

2019

87

PB2207 EARLY SPLEEN RESPONSE IS A GOOD PROGNOSTIC FACTOR OF RUXOLINIB OUTCOME IN PATIENTS WITH MYELOFIBROSIS

Lomaia, E., Siordiya, N., Dimov, G., Senderova, O., Mihalev, M., Furtovskaya, A., Ochirova, O., Li, O., Trizna, K., Otmorskaya, A., Sokurova, E., Khazieva, A., Zaritskey, A.

Journal:

Year:

2019

File:

PDF, 173 KB

2019

88

PB2227 COMPASSIONATE USE OF ROPEGINTERFERON TO TREAT MYELOPROLIFERATIVE NEOPLASMS IN TAIWAN

Chen, C.-C., Kuo, M.-C., Su, Y. -.-J., Huang, C.-E., Hsu, C.-C., Wu, Y.-Y., Chen, Y.-J., Shih, L.-Y.

Journal:

Year:

2019

File:

PDF, 144 KB

2019

89

PB2248 FIRST KOREAN CASE OF THROMBOCYTHEMIA 1 WITH THPO MUTATION (C.13+1G>A, SPLICING) DIAGNOSED BY TARGETED EXOME SEQUENCING

Jung, N., Shim, Y. J., Kim, H. S.

Journal:

Year:

2019

File:

PDF, 388 KB

2019

90

PB2272 A COMPARISON OF 8G AND 11G TREPHINE NEEDLE SIZE ON SAMPLE QUALITY, SUFFICIENCY AND EASE OF PROCEDURE

Murray, D., Wechie, W., Afghan, R., Matthews, P., Mutharasu, A.-D., Tebbet, E., Harrison, B., Nicolle, S.

Journal:

Year:

2019

File:

PDF, 359 KB

2019

91

PB2327 SUBSTITUTING CARMUSTINE WITH BENDAMUSTINE IN BEAM RESULTS IN DELAYED PLATELET RECOVERY AND LESS MUCOSITIS WITH SIMILAR EFFICACY â A MATCHED PAIR ANALYSIS

Aurer, I., Zekanovic, I., Durakovic, N., Batinic, J., Dreta, B., BaÅ¡iÄ-Kinda, S., SertiÄ, D., Roncevic, P., Radman, I., Rincic, G., Bojanic, I., PeriÅ¡a, V., Lozic, D., Petrovic, J., Valkovic, T.

Journal:

Year:

2019

File:

PDF, 274 KB

2019

92

PB2335 COMPARISON BETWEEN FOUR AND FIVE DAYS OF G-CSF-INDUCED MOBILIZATION IN ALLOGENEIC STEM CELL DONORS

Moro, F. Martin, Prieto, C. JimÃ©nez, GarcÃa, I. GarcÃa, RupÃ©rez, A. Sanz, GonzÃ¡lez, S. LÃ³pez, FernÃ¡ndez, B. Michael, MarÃn, A. J. Saez, Stock, C. NÃºÃ±ez-TorrÃ³n, Abia, A. Luna de, NÃºÃ±ez, M.

Journal:

Year:

2019

File:

PDF, 411 KB

2019

93

PB2336 PRIMARY AND SECOND GRAFT FAILURES IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: PRE-TRANSPLANT RECIPIENT / DONOR CYTOMEGALOVIRUS SEROSTATUS CAN HAVE AN EFFECT ON GRAFT FAILURE

Pamukcuoglu, M., Pepeler, M. S., Baysal, N. A., Ulkuden, B., Aki, S. Z., Sucak, G. T.

Journal:

Year:

2019

File:

PDF, 256 KB

2019

94

PF507 THE HEPCIDIN-ERYTHROFERRONE AXIS AND ITS RELATIONSHIP WITH ERYTHROPOIESIS IN DIFFERENT TYPES OF ANEMIA

Del Orbe Barreto, R., Arrizabalaga Amuchastegui, B., MarÃa Jose, M.J., MarÃa Isabel, M.C., Maite, M.G., Salvador, P.P., Sandra, G.R., Pilar, R.A. M., Ana, V.M.

Journal:

Year:

2019

File:

PDF, 766 KB

2019

95

PF601 EVOLVING TREATMENT PATTERNS IN MULTIPLE MYELOMA (MM) DIFFER BY AGE AND REGION: ANALYSIS FROM INSIGHT MM, A GLOBAL, PROSPECTIVE, OBSERVATIONAL STUDY

Chari, A., Weisel, K.C., Usmani, S.Z., Davies, F.E., van Rhee, F., Rifkin, R., Zonder, J.A., Costello, C., Thompson, M.A., Berdeja, J., Lee, H.C., Abonour, R., Omel, J., Hajek, R., Spencer, A., Terpos

Journal:

Year:

2019

File:

PDF, 432 KB

2019

96

PB2198 CRUCIAL AGE FOR JAK2 V617F MUTATION: GENDER DIFFERENCES

Soukhovolsky, V., Olkhovskiy, I., Gorbenko, A., Stolyar, M.

Journal:

Year:

2019

File:

PDF, 322 KB

2019

97

PB2430 CHANGES OF TPA AND PAI-1 IN PATIENTS WITH CORONARY ARTERY DISEASE.

Tyravska, Y., Lizogub, V., Vovk, T., Savchuk, O.

Journal:

Year:

2019

File:

PDF, 146 KB

2019

98

S900 EVIDENCE BASED USE OF ERYTRHOPOIETIN IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA: A MULTICENTER INTERNATIONAL STUDY

Fattizzo, B., Languille, L., Levati, G., Mauro, F. R., Jilma, B., Patriarca, A., Hill, A., Berentsen, S., Michel, M., Barcellini, W.

Journal:

Year:

2019

File:

PDF, 707 KB

2019

99

PF439 EXPLORING THE THERAPEUTIC POTENTIAL OF T-CELL-RECEPTOR REDIRECTED CD3+ NATURAL KILLER CELLS FOR ADOPTIVE CELLULAR THERAPY TO ACUTE MYELOID LEUKEMIA

Wernersbach, J., Khan, S., Bhatti, A., Theobald, M., Hartwig, U.

Journal:

Year:

2019

File:

PDF, 377 KB

2019

100

PB1816 NIVOLUMAB TREATMENT FOR RELAPSED AND REFRACTORY PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA AND PRIMARY TESTICULAR LYMPHOMA WITH CNS INVOLVEMENT

Shmidt, D., Andrey, G., Polushin, A., Kondakova, E., Lepik, K., Zalyalov, Y., Mikhailova, N., Afanasyev, B.

Journal:

Year:

2019

File:

PDF, 166 KB

2019

101

PB1838 EPISTAXIS IN PEDIATRIC TERTIARY OUT-PATIENT CLINIC: COULD IT BE AN ALARMING SIGN?

Elalfy, M., Tantawy, A., Badr Eldin, B.E., Ebeid, F., Mekawy, M.A., Mohammad, Y.

Journal:

Year:

2019

File:

PDF, 439 KB

2019

102

PS1188 AN UPDATED META-ANALYSIS OF THE RISKS OF ARTERIAL AND VENOUS OCCLUSIVE EVENTS WITH NEW GENERATION BCR-ABL TKIS IN PATIENTS WITH CHRONIC MYELOID LEUKAEMIA

Haguet, H., Mullier, F., Graux, C., DognÃ©, J.-M., Douxfils, J.

Journal:

Year:

2019

File:

PDF, 298 KB

2019

103

PB2002 IMPACT OF AUTOIMMUNE CYTOPENIAS ON THE CLINICAL COURSE AND SURVIVAL OF HODGKIN LYMPHOMA

PinczÃ©s, L., SzabÃ³, R., MiltÃ©nyi, Z., IllÃ©s, Ã.

Journal:

Year:

2019

File:

PDF, 147 KB

2019

104

PS1432 3-WEEKLY DARATUMUMAB-IMID-DEXAMETHASONE IS HIGHLY EFFICACIOUS, HENCE FINANCIALLY AFFORDABLE WITH ENORMOUS ECONOMIC IMPACT FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA IN LESS AFFLUENT COUNTRIES

Chim, C.S., Wong, V.K. C., Au, Y.L. E., Kwong, Y.L.

Journal:

Year:

2019

File:

PDF, 724 KB

2019

105

PF299 EARLY RESPONSE OBSERVATION OF PEDIATRIC PATIENTS WITH BURKITT'S LYMPHOMA TREATED WITH CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

Zhang, W.-Q., Hu, B., Jing, L., Yang, J., Du, J., Wang, S., Ren, Y.-L., Liu, Y., Zhang, Y.-H.

Journal:

Year:

2019

File:

PDF, 235 KB

2019

106

PF527 PROTEIN KINASE CK1 ALPHA INACTIVATION CAUSES MANTLE CELL LYMPHOMA GROWTH ARREST AND SYNERGISTICALLY ENHANCES IBRUTINIB CYTOTOXICITY

Manni, S., Carrino, M., Fregnani, A., Tubi, L. Quotti, Visentin, A., Trentin, L., Semenzato, G., Piazza, F.

Journal:

Year:

2019

File:

PDF, 509 KB

2019

107

PS1561 RITUXIMAB-BEAM AND AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR PATIENTS (PTS) WITH RELAPSED FOLLICULAR LYMPHOMA (FL) NOT ABLE TO RECEIVE AN ALLOGENEIC SCT: 8-YEAR MEDIAN FOLLOW-UP RESULTS

Khouri, I., Milton, D., Young, K., Ledesma, C., Alousi, A., Bashir, Q., Ciurea, S., Im, J., Marin, D., Mehta, R., Alatrash, G., Molldrem, J., Olson, A., Oran, B., Popat, U., Qazilbash, M., Rondon, G.,

Journal:

Year:

2019

File:

PDF, 234 KB

2019

108

PF250 HNRNP K OVEREXPRESSION INDUCE NUCLEOLAR STRESS, A HALLMARK OF ACUTE MYELOID LEUKEMIA

Aguilar-Garrido, P., Crespo-GarcÃa, C., Carrasco-Rubio, L., Aitken, M.J., Malaney, P., Zhang, X., Young, K.H., Post, S.M., Martinez-Lopez, J., Gallardo, M.

Journal:

Year:

2019

File:

PDF, 684 KB

2019

109

S1599 RITUXIMAB MAINTENANCE FOR PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA IN FIRST COMPLETE REMISSION: RESULTS FROM A RANDOMIZED HOVON-NORDIC LYMPHOMA GROUP PHASE III STUDY

Lugtenburg, P., Brown, P., van der Holt, B., DâAmore, F., Koene, H., de Jongh, E., Fijnheer, R., Loosveld, O., BÃ¶hmer, L., Pruijt, H., Verhoef, G., Hoogendoorn, M., Bilgin, Y., Nijland, M., Lam, K.

Journal:

Year:

2019

File:

PDF, 373 KB

2019

110

PS1233 HES1 AND HES4 HAVE SIMILAR AND DIVERSE CAPACITIES TO MEDIATE HUMAN NOTCH-DEPENDENT HEMATOPOIETIC LINEAGE DECISIONS

Decker, M. De, Lavaert, M., Roels, J., Tilleman, L., Nieuwerburgh, F. Van, Taghon, T.

Journal:

Year:

2019

File:

PDF, 326 KB

2019

111

PB2110 MRD ANALYSIS IN MULTIPLE MYELOMA: IMMUNOGLOBULIN NGS VERSUS ASO-PCR

Van der Straeten, J., Fostier, K., De Brouwer, W., Demanet, C., Bakkus, M. H.

Journal:

Year:

2019

File:

PDF, 232 KB

2019

112

PS1245 NIVOLUMAB FOR RELAPSED OR REFRACTORY HODGKIN LYMPHOMA: LONG TERM RESULTS OF MULTI-CENTER EXPERIENCE IN TURKEY

Ferhanoglu, B., Ozbalak, M., Bekoz, H., Karadurmus, N., Paydas, S., Turker, A., Toptas, T., Tuglular, T. Firatli, Sonmez, M., Gulbas, Z., Demir, N., Kaynar, L., Yildirim, R., Karadogan, I., Arat, M.,

Journal:

Year:

2019

File:

PDF, 654 KB

2019

113

PF631 HEALTH-RELATED QUALITY OF LIFE WITH POMALIDOMIDE + LOW-DOSE DEXAMETHASONE + DARATUMUMAB IN PATIENTS WITH RELAPSED REFRACTORY MULTIPLE MYELOMA AFTER LENALIDOMIDE TREATMENT

Reece, D., Bahlis, N.J., Samaras, C., Sebag, M., Berdeja, J., Ganguly, S., Matous, J., Song, K., Seet, C.S., Talamo, G., Acosta-Rivera, M., Bar, M., Quick, D., Anz, B., Fonseca, G., Agarwal, A., Chung

Journal:

Year:

2019

File:

PDF, 324 KB

2019

114

PF586 SPARING STEROIDS IN ELDERLY INTERMEDIATE-FIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS TREATED WITH A DOSE/SCHEDULE-ADJUSTED RD-R VS. CONTINUOUS RD: RESULTS OF RV-MM-PI-0752 PHASE III RANDOMIZED STUDY

Larocca, A., Salvini, M., Gaidano, G., Cascavilla, N., Baldini, L., Aglietta, M., Bosi, A., Marasca, R., Spada, S., Ledda, A., Bernardini, A., Falco, P., De Rosa, L., Guglielmelli, T., Zambello, R., P

Journal:

Year:

2019

File:

PDF, 630 KB

2019

115

PF628 O-12-M1: AN EVALUATION OF TIME TO NEXT TREATMENT IN MELFLUFEN AND DEXAMETHASONE-TREATED PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA

Bringhen, S., Richardson, P.G., Voorhees, P., Plesner, T., Mellqvist, U.-H., Zonder, J.A., Reeves, B., Zavisic, S., Harmenberg, J., ObermÃ¼ller, J., Sonneveld, P.

Journal:

Year:

2019

File:

PDF, 383 KB

2019

116

PS948 EXCELLENT RESPONSE TO BLINATUMOMAB IN REFRACTORY B LINEAGE ACUTE LYMPHOBLASTIC LEUKAEMIA IN CHILDREN AND YOUNG ADULTS AFTER DEBULKING CHEMOTHERAPY TO ACHIEVE PARTIAL REMISSION

Clesham, K., Rao, V., Bartram, J., Ancliff, P., Ghorashian, S., OâConnor, D., Pavasovic, V., Rao, A., Samarasinghe, S., Cummins, M., Marks, D., Taylor, G., Nicholson, E., Macartney, C., Patrick, K.,

Journal:

Year:

2019

File:

PDF, 293 KB

2019

117

PS1343 ARE MYELODYSPLASTIC SYNDROMES WITH ISOLATED 20Q DELETION A DIFFERENT CLINICAL-BIOLOGICAL ENTITY?

Campagna, A., De Benedittis, D., Fianchi, L., Niscola, P., Piccioni, A., Di Veroli, A., Mancini, S., VillivÃ , N., Mohamed, S., Carmosino, I., Criscuolo, M., Fenu, S., Spiriti, M.A. Aloe, Buccisano, F

Journal:

Year:

2019

File:

PDF, 427 KB

2019

118

PS1413 INCIDENCE OF NEGATIVE MINIMAL RESIDUAL DISEASE IN MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS STEM CELL TRANSPLANT

Afonso, C., Roque, A., Nascimento, T., Sarmento, A.B., Geraldes, C., Paiva, A., Ribeiro, L.

Journal:

Year:

2019

File:

PDF, 404 KB

2019

119

PF285 ZELLA-101: PHASE 1 STUDY OF ALVOCIDIB FOLLOWED BY 7+3 INDUCTION IN NEWLY DIAGNOSED AML PATIENTS

Lee, D., Smith, B., Frattini, M., Anthony, S., Bearss, D., Zeidner, J.

Journal:

Year:

2019

File:

PDF, 408 KB

2019

120

PB2435 PROTEIN S DEFICIENCY AND ISCHAEMIC STROKE

Kazantzi, A., Girtovitis, F., Voulgaridou, V., Savopoulos, C., Hassapopoulou-Matami, E., Hatzitolios, A.

Journal:

Year:

2019

File:

PDF, 245 KB

2019

121

PB2302 MATCHED SIBLING DONOR ALLOGENEIC STEM CELL TRANSPLANTATION WITH NON-MYELOABLATIVE CONDITIONING PRECEDED BY AZATHIOPRINE AND HYDROXYUREA PRECONDITIONING IN ADULT SICKLE CELL PATIENTS

Nur, E., Gaartman, A., van Tuijn, C., Suijk, L., Hazenberg, M., Biemond, B.

Journal:

Year:

2019

File:

PDF, 398 KB

2019

122

PB2159 CHOLESTEROL LEVELS PROVIDE PROGNOSTIC INFORMATION IN PATIENTS WITH MULTIPLE MYELOMA

Journal:

Year:

2019

File:

PDF, 154 KB

2019

123

PS1470 EFFICACY AND SAFETY OF ANAGRELIDE IN OLDER PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA

Buxhofer-Ausch, V., Steurer, M., Sormann, S., Forjan, E., Schimetta, W., Gisslinger, B., Heibl, S., Krauth, M.-T., Thiele, J., Ruckser, R., Gastl, G., Gisslinger, H.

Journal:

Year:

2019

File:

PDF, 550 KB

2019

124

PF242 LONG NON-CODING RNA MANTIS INHIBITS THE PROLIFERATION OF ACUTE MYELOID LEUKEMIA CELL LINE VIA NOTCH SIGNALING PATHWAY

Wang, H., Jiao, Y., Zhang, G., Liu, Z.

Journal:

Year:

2019

File:

PDF, 281 KB

2019

125

PB2016 RESULTS OF TREATMENT PATIENTS OF MANTLE CELL LYMPHOMA DEPENDING ON THE MUTATIONAL STATUS OF THE TP53 GENE

Koroleva, D., Zvonkov, E., Gabeeva, N., Smolyaninova, A., Gavrilina, O., Shchetsova, O., Biderman, B., Tsygankova, S., Bulygina, E., Rastorguev, S., Nedoluzhko, A., Sudarikov, A., Kovrigina, A., Galts

Journal:

Year:

2019

File:

PDF, 273 KB

2019